Compound Detail
CHEMBL261907
DIHYDRODEHYDRODICONIFERY ALCOHOL Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL261907 |
| Name | DIHYDRODEHYDRODICONIFERY ALCOHOL |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SBLZVJIHPWRSQQ-HNAYVOBHSA-N |
5
Targets
7
Activities
1
Assay Types
0
PK Parameters
15
Publications
0
Known Names
Molecular Properties
360.4
MW (Da)
2.54
ALogP
6
HBA
3
HBD
88.4
PSA (Ų)
0.70
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 5.01
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| RAW264.7 | IC50 | = | 9800.0 | nM | 5.01 | Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells preinc... | 21435874 |
| XF498 | IC50 | = | 13420.0 | nM | 4.87 | Anticancer activity against human XF498 cells by SRB assay | 21420296 |
| A549 | IC50 | = | 22400.0 | nM | 4.65 | Anticancer activity against human A549 cells by SRB assay | 21420296 |
| SK-MEL-2 | IC50 | = | 23340.0 | nM | 4.63 | Anticancer activity against human SK-MEL-2 cells by SRB assay | 21420296 |
| BV-2 | IC50 | = | 28800.0 | nM | 4.54 | Antiinflammatory activity in mouse BV2 cells assessed as inhibition of lipopolys... | 21420296 |
| RAW264.7 | IC50 | = | 38700.0 | nM | 4.41 | Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of... | 24035341 |
| RAW264.7 | IC50 | = | 60400.0 | nM | 4.22 | Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS/... | 31350127 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16413779 | 10.1016/j.bmcl.2005.12.032 | B16-F10 | 3 |
| 16413779 | 10.1016/j.bmcl.2005.12.032 | HT-1080 | 3 |
| 23434030 | 10.1016/j.bmcl.2013.01.046 | Hepatitis B virus | 3 |
| 16413779 | 10.1016/j.bmcl.2005.12.032 | U-937 | 2 |
| 24035341 | 10.1016/j.bmcl.2013.08.004 | RAW264.7 | 2 |
| 31350127 | 10.1016/j.bmcl.2019.07.026 | RAW264.7 | 2 |
| 21420296 | 10.1016/j.bmcl.2011.02.104 | BV-2 | 1 |
| 21420296 | 10.1016/j.bmcl.2011.02.104 | A549 | 1 |
| 21420296 | 10.1016/j.bmcl.2011.02.104 | SK-MEL-2 | 1 |
| 21420296 | 10.1016/j.bmcl.2011.02.104 | XF498 | 1 |
| 21420296 | 10.1016/j.bmcl.2011.02.104 | SK-OV-3 | 1 |
| 21435874 | 10.1016/j.bmcl.2011.02.102 | RAW264.7 | 1 |
| 23434030 | 10.1016/j.bmcl.2013.01.046 | ADMET | 1 |
| 31350127 | 10.1016/j.bmcl.2019.07.026 | Acetylcholinesterase | 1 |
| 33939429 | 10.1021/acs.jnatprod.1c00146 | RAW264.7 | 1 |
Data from ChEMBL 36 via Core Engine